Screener
Alnylam Pharmaceuticals ALNY Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Alnylam Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Alnylam Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 8:11 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001178670-26-000062
FAQ
- What is Alnylam Pharmaceuticals's gross margin?
- Alnylam Pharmaceuticals (ALNY) reported gross margin of 79.8% in Q2 2026.
- How has Alnylam Pharmaceuticals's gross margin changed year-over-year?
- Alnylam Pharmaceuticals's gross margin decreased by 4.9% year-over-year, from 83.9% to 79.8%.
- What is the long-term trend for Alnylam Pharmaceuticals's gross margin?
- Over 5 years (2020 to 2025), Alnylam Pharmaceuticals's gross margin has grown at a -0.6% compound annual growth rate (CAGR), from 84.2% to 81.8%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Alnylam Pharmaceuticals's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude